Total solution to reduce preanalytical errors, revealed
Streamline point-of-care testing
Effective and efficient whole blood hemolysis detection can help reduce unnecessary sample collection, manual intervention, delays, and inappropriate treatment. Ultimately, it can lead to optimized staff time, reduced costs, and improved patient management.1–5
Simplicity
All-in-one GEM PAK™ cartridge automates labor- and skill-intensive processes, offering a variety of menu and test-volume configurations, tailored to acute care settings (e.g., ED, NICU, ICU, OR), for ultimate flexibility.
- Patented technology—hemolysis detection, similar to traditional laboratory analyzers
- Zero maintenance—disposable GEM PAK cartridges are replaced every 31 days; no additional handling required
- Ensures patient and operator safety—all components are self-contained, and no blood enters the instrument, limiting biohazard exposure
- Ultimate simplicity—easy front-loading and room-temperature storage
Quality ensured
Only Intelligent Quality Management 3 (iQM3*) ensures the integrity of every sample. It also detects hemolysis in 45 seconds, helping inform appropriate patient management decisions.6
- Hemolysis Detection—detects hemolysis during sample measurement
- IntraSpect Checks—detects transient sample-specific errors missed by traditional quality control (QC) methods
- Sensor Checks—runs five levels of Process Control Solutions (PCS) for real-time error detection, significantly exceeding traditional QC intervals
- Pattern Recognition Checks—identifies common errors, including micro-clots and interferences (e.g., thiopental, benzalkonium), and integrates auto-corrective actions
- PCS Stability Checks—verifies stability of PCS and GEM PAK integrity during cartridge use-life
- System Checks—ensures the function of vital system components before each sample analysis
Control
GEMweb® Plus 500 Custom Connectivity simplifies control and compliance, enabling continuous quality improvement.
- Customizable connectivity and automated functionality for comprehensive management of systems, operators, and data oversight
- Sample Handling Report helps identify operator competency gaps and training needs, for improved sample quality
- Simple web access from any browser
Testimonials
Chris W. Farnsworth, PhD
Associate Professor, Pathology and Immunology
Washington University School of Medicine
Medical Director, Clinical Chemistry, and Point-of-Care Testing
Barnes Jewish Hospital
St Louis, MO
One game-changing breakthrough in 2024 was the emergence of hemolysis detection in whole blood for blood gas testing with the GEM Premier 7000.
Heather Stieglitz, PhD, D (ABCC)
Co-Director, Clinical Chemistry and Toxicology
Ohio State University, Wexner Medical Center
Clinical Assistant Professor, Department of Pathology
Ohio State University College of Medicine
Columbus, OH
Hemolysis is an important preanalytical variable that definitely occurs in blood gas samples at the point of care, and we were not able to detect it before. Werfen’s is the first testing system that allows us to measure for that potential preanalytical variable in these samples.